These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16006372)

  • 1. Welcome to ordinary? Marketing better boys.
    Hall AL
    Am J Bioeth; 2005; 5(3):59-60; discussion W10-2. PubMed ID: 16006372
    [No Abstract]   [Full Text] [Related]  

  • 2. New Ritalin ad blitz makes parents jumpy.
    Novak V
    Time; 2001 Sep; 158(10):62-3. PubMed ID: 11558351
    [No Abstract]   [Full Text] [Related]  

  • 3. DSM-IV supervisor voices concerns about the diagnostic manual.
    Kouros N
    Monash Bioeth Rev; 2013 Sep; 31(2):16-7. PubMed ID: 24844064
    [No Abstract]   [Full Text] [Related]  

  • 4. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN
    J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
    [No Abstract]   [Full Text] [Related]  

  • 6. Attention Deficit Hyperactivity Disorder. Health visitors can help parents get a grip.
    Coombes R
    Nurs Times; 2000 May; 96(19):13. PubMed ID: 11962267
    [No Abstract]   [Full Text] [Related]  

  • 7. ADHD, values, and the self.
    Litton P
    Am J Bioeth; 2005; 5(3):65-7; discussion W10-2. PubMed ID: 16006360
    [No Abstract]   [Full Text] [Related]  

  • 8. Authentic faux diamonds and attention deficit disorder.
    Anijar K; Gabbard D
    Am J Bioeth; 2005; 5(3):67-70. PubMed ID: 16006371
    [No Abstract]   [Full Text] [Related]  

  • 9. Why is there a gender gap in children presenting for attention deficit/hyperactivity disorder services?
    Ohan JL; Visser TA
    J Clin Child Adolesc Psychol; 2009 Sep; 38(5):650-60. PubMed ID: 20183650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents' beliefs and attributions.
    Johnston C; Seipp C; Hommersen P; Hoza B; Fine S
    Child Care Health Dev; 2005 Nov; 31(6):669-77. PubMed ID: 16207224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of attention-deficit-hyperactivity disorder and conduct disorder in Mexican children by the scale for evaluation of deficit of attention and hyperactivity.
    Zambrano-Sánchez E; Martínez-Cortés JA; Del Rió-Carlos Y; Martínez-Wbaldo Mdel C; Poblano A
    Psychiatry Res; 2011 May; 187(3):437-40. PubMed ID: 20934222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychostimulant rebound in attention deficit disordered boys.
    Johnston C; Pelham WE; Hoza J; Sturges J
    J Am Acad Child Adolesc Psychiatry; 1988 Nov; 27(6):806-10. PubMed ID: 3198571
    [No Abstract]   [Full Text] [Related]  

  • 15. Parents' causal attributions about attention deficit/hyperactivity disorder: the effect of child and parent sex.
    Maniadaki K; Sonuga-Barke E; Kakouros E
    Child Care Health Dev; 2005 May; 31(3):331-40. PubMed ID: 15840153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemoline (Cylert): market withdrawal.
    Hogan V
    CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
    [No Abstract]   [Full Text] [Related]  

  • 17. Is ADHD a growth industry?
    Goldstein S
    J Atten Disord; 2006 Feb; 9(3):461-4. PubMed ID: 16481662
    [No Abstract]   [Full Text] [Related]  

  • 18. Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication.
    Saylor KE; Buermeyer CM; Spencer TJ; Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():23-8. PubMed ID: 12562058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives.
    Berger I; Dor T; Nevo Y; Goldzweig G
    J Child Neurol; 2008 Sep; 23(9):1036-42. PubMed ID: 18487521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.